Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Change in Intangibles (2019 - 2023)

Historic Change in Intangibles for OptimizeRx (OPRX) over the last 4 years, with Q3 2023 value amounting to $1000.0.

  • OptimizeRx's Change in Intangibles fell 9234.54% to $1000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was -$48441.0, marking a year-over-year increase of 6649.56%. This contributed to the annual value of $1830.0 for FY2022, which is 9149.27% down from last year.
  • According to the latest figures from Q3 2023, OptimizeRx's Change in Intangibles is $1000.0, which was down 9234.54% from -$156491.0 recorded in Q4 2022.
  • OptimizeRx's Change in Intangibles' 5-year high stood at $500000.0 during Q4 2019, with a 5-year trough of -$302902.0 in Q4 2021.
  • Moreover, its 4-year median value for Change in Intangibles was $57982.0 (2021), whereas its average is $52434.1.
  • As far as peak fluctuations go, OptimizeRx's Change in Intangibles surged by 4833.61% in 2022, and later tumbled by 9234.54% in 2023.
  • Quarter analysis of 4 years shows OptimizeRx's Change in Intangibles stood at $500000.0 in 2019, then plummeted by 160.58% to -$302902.0 in 2021, then surged by 48.34% to -$156491.0 in 2022, then soared by 100.64% to $1000.0 in 2023.
  • Its last three reported values are $1000.0 in Q3 2023, -$156491.0 for Q4 2022, and $13064.0 during Q3 2022.